Guardian Pharmacy Services, Inc. 8-K

What Happened
On January 13, 2026, Guardian Pharmacy Services, Inc. (GRDN) filed a Form 8-K to announce a press release that reiterates the company’s previously issued financial guidance for the full year ended December 31, 2025 and to provide a preliminary financial outlook for 2026. The company also published a presentation it plans to use at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 (approximately 4:30 p.m. PT) and for investor meetings.

Key Details

• Press release filed and furnished as Exhibit 99.1 on January 13, 2026; it reiterates prior FY2025 guidance rather than revising it.
• The filing includes the company’s preliminary financial outlook for calendar year 2026 (details are provided in the furnished materials).
• Company presentation for the 44th Annual J.P. Morgan Healthcare Conference (Jan 14, 2026, ~4:30 p.m. PT) was furnished as Exhibit 99.2.
• The 8-K was filed under Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure).

Why It Matters
For investors, a reaffirmation of FY2025 guidance signals management is maintaining its prior expectations for revenue, earnings drivers, or other financial metrics (rather than lowering or raising targets). The preliminary 2026 outlook and the JP Morgan presentation provide updated forward-looking information and give analysts and investors a chance to hear management’s strategy and assumptions. Review the attached press release and presentation (Exhibits 99.1 and 99.2) for the specific numbers and assumptions underlying the outlook before making investment decisions.